Concorde Asset Management’s Medpace MEDP Stock Holding History

Concorde Asset Management’s Portfolio MEDP Stock Details MEDP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-527	Closed	-$296K	–	235
2025 Q4	$296K	Hold	527	–	–	0.12%	161
2025 Q3	$284K	Buy	+527	New	+$230K	0.12%	159

Other funds holding MEDP

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Concorde Asset Management's MEDP Position: Q1 2026 in Review

Concorde Asset Management sold out of Medpace (MEDP) in Q1 2026, closing a stake of 527 shares — an estimated $296K sold.

Concorde Asset Management first reported a position in MEDP in Q3 2025 and held it in 2 quarters. The position peaked at $296K in Q4 2025. 729 funds tracked by Wall St. Rank hold MEDP as of Q1 2026.

Concorde Asset Management reported no remaining Medpace position as of Q1 2026 after selling out during the quarter.
Concorde Asset Management sold 527 Medpace shares in Q1 2026, an estimated $296K.
Concorde Asset Management first reported a position in Medpace in Q3 2025 and held it in 2 quarters.
Concorde Asset Management's Medpace position peaked at $296K in Q4 2025.
729 funds tracked by Wall St. Rank held Medpace as of Q1 2026.

Based on Concorde Asset Management's 13F filing for Q1 2026, filed 1 Jun 2026.